A unique late complication with the use of calcium hydroxylapatite filler in facial lipoatrophy rehabilitation | Zendy

Raffaele Rauso | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

A unique late complication with the use of calcium hydroxylapatite filler in facial lipoatrophy rehabilitation

Author(s) -

Raffaele Rauso

Publication year - 2014

Publication title -

plastic and aesthetic research

Language(s) - English

Resource type - Journals

eISSN - 2349-6150

pISSN - 2347-9264

DOI - 10.4103/2347-9264.143563

Subject(s) - medicine , filler (materials) , facial rejuvenation , complication , hydroxylapatite , lipoatrophy , dermatology , rehabilitation , dentistry , surgery , physical therapy , composite material , immunology , biochemistry , chemistry , materials science , human immunodeficiency virus (hiv) , antiretroviral therapy , viral load , enzyme

Radiesse (Merz Aesthetics, Franksville, WI, USA) is an injectable filler material composed of synthetic calcium hydroxylapatite (CaHA) microspheres suspended in an aqueous carrier gel. Cosmetic use of Radiesse in facial rejuvenation is well-known. Treatment sites amenable to calcium hydroxylapatite (CH) injection include the naso-labial folds, marionette lines, perioral lines, prejowl sulcus, zygoma and malar eminence, tear trough depressions, nose, chin, acne scars, and it is also Food and Drug Administration-approved for facial augmentation in HIV patients with facial lipo-atrophy.[1]

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research